Strides Pharma Science Limited has informed the Exchange about change in Management
STAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Strides Pharma's Board approved multiple management changes effective June 1, 2026. Key change: COO Ram (Venkata Seetharama Raju Pakalapati) is elevated to Executive Director and KMP, marking an internal promotion after 18 years with the company. Aditya Arun Kumar, currently Executive Director – Business Development, voluntarily resigned from his executive role and was redesignated as Non-Executive Director, in line with the promoter's stated intention to further professionalise management. Nandini Matiyani was redesignated as Group CHRO and Ariff Khan (EVp – Manufacturing Operations) was newly added to the SMP list. Aditya is the son of Founder & Non-Executive Chairperson Arun Kumar and remains on the Board as a Non-Executive Director.
The elevation of an internal long-tenure executive and the voluntary stepping down of a promoter family member from an executive role signals a planned management transition and professionalisation push, generally viewed positively by markets as it strengthens governance.